C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
11/2001
11/13/2001	US6316625 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316455 Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound
11/13/2001	US6316450 Compounds
11/13/2001	US6316389 Dihydrobenzene pesticides
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083430A2 Method for oxidizing tertiary amines and aromatic heterocycles containing nitrogen
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	US20010039352 Production method of isoxazolidinedione compound
11/08/2001	US20010039344 Antidiabetic agents
11/08/2001	DE10020630A1 Verfahren zur Oxidation von tertiären Aminen und Stickstoff-haltigen aromatischen Heterocyclen A process for the oxidation of tertiary amines and nitrogen-containing aromatic heterocycles
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407189A1 New gamma selective retinoids
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP0923565B1 Process for preparing paclitaxel
11/07/2001	EP0843673B1 One pot synthesis of 2-oxazolidinone derivatives
11/07/2001	EP0776322B1 Method for the preparation of taxol and its derivatives
11/07/2001	EP0740660B1 Substituted oxazolines
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	US6313338 Ace inhibitor intermediate
11/06/2001	US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides
11/06/2001	US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
11/06/2001	US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001	US6313275 Free radical catalysts for olefin (co)polymerization; endcapping with heterocyclic groups; block and graft polymerization
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/01/2001	WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
11/01/2001	WO2001080841A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036653 Stereo-specific synthesis of shimikic acid derivatives with improved efficiency
11/01/2001	CA2405543A1 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
10/2001
10/31/2001	EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001	EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001	EP0719258B1 Cyclic amide derivatives for protecting against ultraviolet rays
10/31/2001	CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/30/2001	US6310189 Nucleotides and analogs having photoremoveable protecting groups
10/30/2001	US6310096 Cyclohexadiene-derivatives as pesticides
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310081 Protein tyrosine phosphatase inhibitors
10/30/2001	US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/25/2001	WO2001079202A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
10/25/2001	WO2001078714A1 Novel compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans
10/25/2001	WO2001078654A2 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	WO2000056724A9 Oxazole and thiazole combinatorial libraries
10/25/2001	US20010034371 Antidiabetic agents
10/25/2001	US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001	CA2402374A1 Processes for the preparation of thiazolidinedione derivatives and intermediates
10/24/2001	EP1147422A1 Assays for modulators of "elongation factor p" activity
10/24/2001	EP1147101A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
10/24/2001	EP0648212B1 Benzoxazole and benzothiazole derivatives as pharmaceutical
10/24/2001	CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001	CN1318536A Substituted biphenyl oxazoline
10/24/2001	CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/23/2001	US6307064 Process to prepare taxol
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306881 Anti-inflammatory agents
10/18/2001	WO2001077107A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors
10/18/2001	WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/18/2001	WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031786 Antidiabetic agents, obesity
10/18/2001	US20010031764 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
10/18/2001	US20010031762 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
10/18/2001	CA2404760A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors
10/18/2001	CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/17/2001	EP1146036A2 Tamiflu, Gallocarboxylic acid approach
10/17/2001	EP1144399A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
10/17/2001	EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001	EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001	EP1144394A1 1-heterocycle substituted diarylamines
10/17/2001	EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
10/17/2001	EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001	EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP0641330B1 Gaba and l-glutamic acid analogs for antiseizure treatment
10/17/2001	CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation
10/17/2001	CN1318060A Sulfonyl oxazolones
10/17/2001	CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination
10/17/2001	CN1317481A Method for preparing 4,5-diamino shikimic acid derivative
10/17/2001	CN1317480A One-step process for synthetizing 2-oxazolidone derivative
10/17/2001	CN1073097C Aniline derivatives having herbicidal activity their prepn. and their use
10/16/2001	US6303791 One pot synthesis of 2-oxazolidinone derivatives
10/16/2001	US6303786 Salt formation in a solvent
10/16/2001	US6303640 Administering oxazole or thiazole derivative compound for reducing side effects of diabetic therapy
10/11/2001	WO2001074910A2 Ether-amine based polymerization catalysts, compositions and processes using same
10/11/2001	WO2001074792A2 Process for the preparation of matrix metalloproteinase inhibitors
10/11/2001	WO2001074786A1 Heterobiarylsulphonamides and their use as pde 7 inhibitors
10/11/2001	WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001	WO2001074506A1 Extrusion die
10/11/2001	US20010029256 Peroxisome proliferator activator receptor; dietetics, antidiabetic agents

1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 210